Health savings accounts continue to be adopted widely, with an ever-growing number of accounts and assets. Between January 2008 and January 2009, participants in the latest HSA benchmarking survey from Celent experienced a 46.1% increase in the number of HSAs. During the same period, survey participants saw their asset base grow by 62.6%.
This will likely turn out to be the year that significant healthcare reform is written into legislation in the US. Health savings accounts (HSAs) are expected to survive these reforms, and for good reason. If healthcare reforms were to write HSAs out of existence, they would discard all the efforts behind one of the fastest-growing retail banking products today.
One of the main findings of Celent’s most recent HSA benchmarking exercise is the robust growth of HSAs. Other key findings include:

"HSA pricing continues to decline, with average collected monthly fees now hovering just above the $2 mark," says Red Gillen, senior analyst with Celent's Banking group and author of the report. "In fact, some HSA players are even preparing for the eventuality when HSAs go the way of checking accounts. In other words, free."
This research is an update of Celent’s previous HSA benchmarking reports and contains newly collected information. This report measures banks' most relevant HSA performance criteria and provides an analysis of underlying factors and trends.
The 44-page report contains 26 figures A table of contents for this report is available online.
Members of Celent’s Healthcare Banking research service can download the report electronically by clicking the icon to the left. Non-members should contact info@celent.com for more information.
Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies. Celent publishes reports identifying trends and best practices in financial services technology and conducts consulting engagements for financial institutions looking to use technology to enhance existing business processes or launch new business strategies. With a team of internationally experienced analysts, Celent is uniquely positioned to offer strategic advice and market insights on a global basis. Celent is a member of the Oliver Wyman Group, which is part of Marsh & McLennan Companies [NYSE: MMC].
New York - Dana Lautin
dlautin@celent.com
Tel.: +1 646 364 8254
Paris - Alexandra Vouge
avouge@celent.com
Tel.: +33.1.73.04.46.26
Tokyo - Yumi Nagaoka
ynagaoka@celent.com
Tel.: +81.3.3596.0020